CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review

• Published in: Cellular & molecular biology letters Vol. 26; no. 1; pp. 41 - 29
• Main Authors: Foruzandeh, Zahra, Zeinali-Sehrig, Fatemeh, Nejati, Kazem, Rahmanpour, Dara, Pashazadeh, Fariba, Seif, Farhad, Alivand, Mohammad Reza
• Format: Journal Article
• Language: English
• Published: England BioMed Central 23.09.2021; BMC
• Subjects: Apoptosis; Autophagy; Biomarkers; Biomarkers, Tumor - genetics; Cancer therapies; Cell cycle; Cell growth; Cell proliferation; Chemoresistance; Chemotherapy; Circular RNA (CircRNA); Female; Gene expression; Humans; Malignancy; Medical prognosis; Metastases; Metastasis; MicroRNAs - genetics; miRNA; Ovarian cancer; Ovarian cancer (OC); Ovarian Neoplasms - genetics; Ovarian Neoplasms - metabolism; Pathogenesis; Prognosis; Review Letter; RNA, Circular - genetics; Therapeutic targets; Tumorigenesis; Circular RNA (CircRNA); Ovarian cancer (OC)
• ISSN: 1425-8153; 1689-1392; 1689-1392
• DOI: 10.1186/s11658-021-00284-7

More powerful prognostic and diagnostic tools are urgently needed for identifying and treating ovarian cancer (OC), which is the most fatal malignancy in women in developed countries. Circular RNAs (circRNAs) are conservative and stable looped molecules that can regulate gene expression by competing with other endogenous microRNA sponges. This discovery provided new insight into novel methods for regulating genes that are involved in many disorders and cancers. This review focuses on the dysregulated expression of circRNAs as well as their diagnostic and prognostic values in OC. We found that studies have identified twenty-one downregulated circRNAs and fifty-seven upregulated ones. The results of these studies confirm that circRNAs might be potent biomarkers with diagnostic, prognostic and therapeutic target value for OC. We also consider the connection between circRNAs and OC cell proliferation, apoptosis, metastasis, and chemotherapy resistance and sensitivity.